Scholarlink

<p>Epigenetic dysregulation plays a pivotal role in cancer progression. Unlike HP1α and HP1β, which localize primarily to heterochromatin, HP1γ predominantly occupies euchromatin, suggesting a direct role in transcriptional regulation. Here, we identify HP1γ as a high-risk oncogene in colorectal cancer (CRC). Genome-wide analysis and disease-free survival (DFS) correlation studies revealed that high expression of HP1γ is associated with poor DFS in CRC patients, and we confirmed HP1γ upregulation in colon adenocarcinoma (COAD), the predominant CRC subtype. Functional assays demonstrated that HP1γ overexpression enhances tumor cell proliferation, migration, and colony formation <i>in vitro</i>, while siRNA-mediated knockdown suppressed these phenotypes. <i>In vivo</i> studies showed that HP1γ drives tumor growth, increasing both volume and weight in xenograft models. Mechanistically, HP1γ, via its chromo shadow domain (CSD), physically interacts with the beta-transducin repeat domain (BTD) of recombination signal binding protein for immunoglobulin kappa J region (RBPJ), the transcriptional factor of the Notch pathway. Intriguingly, RBPJ upregulation counteracts HP1γ-induced hyperproliferation, implicating HP1γ as a critical modulator of Notch signaling. Our findings establish HP1γ as a promoter of CRC progression through suppression of Notch pathway components, highlighting its potential as a diagnostic marker or therapeutic target in CRC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

HP1γ promotes the progression of colorectal cancer through interaction with RBPJ of the Notch signaling pathway

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月1日

查看全文
  • Rui-Bao Zhu,
  • Yi-Jia Xie,
  • Yu-Ting Han,
  • Bo Peng,
  • Wen-Ting Wang,
  • Xin-Yi Lu,
  • Yu-Tong Li,
  • De-Cai Mao,
  • Jin Sun,
  • De-Xin Chen,
  • Qin-Yun Che,
  • Li Zheng,
  • Dong-Lin Li,
  • Feng-Rui Hou,
  • Meng-Lin Mo,
  • Shi-Yao Gong,
  • Yi-Zhi Dong,
  • Rong-Zhi Fu,
  • Qing-Fei Liu,
  • Fang-Lin Sun,
  • Zhi-Jie Chang,
  • Jian-Quan Ni,
  • Ming-Yang Li

摘要

Epigenetic dysregulation plays a pivotal role in cancer progression. Unlike HP1α and HP1β, which localize primarily to heterochromatin, HP1γ predominantly occupies euchromatin, suggesting a direct role in transcriptional regulation. Here, we identify HP1γ as a high-risk oncogene in colorectal cancer (CRC). Genome-wide analysis and disease-free survival (DFS) correlation studies revealed that high expression of HP1γ is associated with poor DFS in CRC patients, and we confirmed HP1γ upregulation in colon adenocarcinoma (COAD), the predominant CRC subtype. Functional assays demonstrated that HP1γ overexpression enhances tumor cell proliferation, migration, and colony formation in vitro, while siRNA-mediated knockdown suppressed these phenotypes. In vivo studies showed that HP1γ drives tumor growth, increasing both volume and weight in xenograft models. Mechanistically, HP1γ, via its chromo shadow domain (CSD), physically interacts with the beta-transducin repeat domain (BTD) of recombination signal binding protein for immunoglobulin kappa J region (RBPJ), the transcriptional factor of the Notch pathway. Intriguingly, RBPJ upregulation counteracts HP1γ-induced hyperproliferation, implicating HP1γ as a critical modulator of Notch signaling. Our findings establish HP1γ as a promoter of CRC progression through suppression of Notch pathway components, highlighting its potential as a diagnostic marker or therapeutic target in CRC.